CAR-T cell therapy (Chimeric Antigen Receptor T-cell therapy) is an autologous or allogeneic cell-based immunotherapy in which a patient's T cells are genetically engineered to express a chimeric antigen receptor (CAR) that enables them to recognize and destroy cancer cells expressing a specific target antigen.
